Liposome-like nanocapsules of dual drug-tailed betaine for cancer therapy
Eligibility criteria We included RCTs with a duration of intervention of at least 12 weeks that compared tirzepatide at a maintenance dose of 5, 10 or 15 mg once-weekly, administered subcutaneously, with placebo or any other glucose-lowering medication
Ideal candidates typically: Have struggled with weight control despite lifestyle modification Display signs of insulin resistance or metabolic syndrome Require medical assistance to prevent progression of obesity-related diseases Exclusion criteria may include individuals with a history of certain endocrine disorders, pancreatitis, or specific gastrointestinal diseases
Sudden discontinuation can lead to rapid weight regain, so any changes should be discussed with your doctor first
They present as hyperkeratotic papules or plaques, usually asymptomatic unless fissuring or secondary bacterial infection occurs
Ensure that you empty your bowels before inserting the suppository Remove the plastic wrapping from one suppository Insert it gently into the rectum (narrow end first) past the sphincter muscles with your finger